- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Solid Malignancies in Singapore
Total 113 results
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
National University Hospital, SingaporeSchool of Computing, National University of Singapore; Cancer Science Institute...RecruitingSolid Organ MalignanciesSingapore
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
S*BIOCompletedMyelodysplastic Syndrome | Solid Tumors | Hematologic MalignanciesUnited States, Singapore
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; ASLAN PharmaceuticalsActive, not recruiting
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeRecruiting
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeNatera, Inc.; The N.1 Institute for Health (N.1)Recruiting
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
Kyowa Kirin Co., Ltd.Terminated
-
National University Hospital, SingaporeUnknownSolid Tumor CancerSingapore
-
Yantai LNC Biotechnology Singapore PTE. LTD.Recruiting
-
National University Hospital, SingaporeRecruiting
-
Otsuka Beijing Research InstituteCompletedMalignant Solid TumourSingapore
-
National Cancer Centre, SingaporeCompletedUnspecified Adult Solid Tumor, Protocol SpecificSingapore
-
National University Hospital, SingaporeUnknownHaematological Malignancies | Acquired Aplastic AnaemiaSingapore
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1)Recruiting
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsAustralia, Singapore
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
EDDC (Experimental Drug Development Centre), A*STAR...ParexelRecruiting
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1); Cancer Science Institute of SingaporeNot yet recruitingBreast Cancer | Solid Tumor | Gastrointestinal CancerSingapore
-
National University Hospital, SingaporeAdagene IncRecruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | LymphomasSingapore
-
Debiopharm International SATerminatedSolid TumoursKorea, Republic of, United States, Taiwan, Spain, Singapore
-
National Cancer Centre, SingaporeNovartisCompleted
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
National Cancer Centre, SingaporeSingapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...RecruitingNon-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid TumoursSingapore
-
National Cancer Centre, SingaporeTerminatedUnspecified Adult Solid Tumor, Protocol Specific | Palmar-plantar Erythrodysesthesia | Dermatologic ComplicationsSingapore
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Non Hodgkin's Lymphoma | Hodgkin's DiseaseSingapore
-
National Cancer Centre, SingaporeNovartisUnknownNasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid TumourSingapore
-
National University Hospital, SingaporeUnknownBreast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid TumorsSingapore
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
BioNTech SERecruitingSolid TumorUnited States, Spain, Singapore, United Kingdom
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Taiwan, Spain, Canada, Italy, Singapore, Japan, Hong Kong
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesTaiwan, Netherlands, Italy, Korea, Republic of, Japan, United States, Switzerland, Canada, Singapore